For research use only
| Cat No. | ABC-X0286C |
| Product Type | Overexpression Stable Cell Lines |
| Cell Type | Lymphocytes |
| Species | Human |
| Host Cell | BAF3 |
| Source Organ | Lymphatic |
| Disease | Normal |
| Storage | Liquid Nitrogen |
The human ERBB2 (V956R) BAF3 Cell Line allows investigation of HER2 mutation-driven oncogenesis and targeted drug sensitivity in cancer cells.
Human ERBB2 (V956R) BAF3 Cell Line is a genetically engineered model derived from murine Ba/F3 cells with stable integration of human ERBB2 gene carrying the V956R activating mutation. The cell line was generated using lentiviral transduction and expanded under low passage conditions (<P20). Expression is confirmed by qRT-PCR. Target ERBB2 (HER2) is a member of the ERBB receptor tyrosine kinase family involved in cell growth and differentiation. The V956R mutation occurs within the kinase domain, enhancing dimerization and downstream signaling. It is implicated in drug resistance in HER2-positive cancers. AcceGen offers generation of stable overexpression cell lines targeting any gene of your interest. Polyclonal or monoclonal is optional based on customers' research needs.
| Species | Human |
| Cat.No | ABC-X0286C |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Lymphocytes |
| Growth Mode | Suspension |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 °C, 5% CO2 |
| Source Organ | Lymphatic |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Overexpression Stable Cell Lines |
| Host Cell | BAF3 |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
This model is ideal for evaluating ERBB2 mutation-driven signaling, HER2-targeted therapy response, and resistance mechanisms in hematologic and solid tumor settings.